|
1
|
Xu Y, Wang L, He J, Bi Y, Li M, Wang T,
Wang L, Jiang Y, Dai M, Lu J, et al: Prevalence and control of
diabetes in Chinese adults. JAMA. 310:948–959. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Galuppo M, Giacoppo S, Bramanti P and
Mazzon E: Use of natural compounds in the management of diabetic
peripheral neuropathy. Molecules. 19:2877–2895. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bongaerts BW, Rathmann W, Kowall B, Herder
C, Stöckl D, Meisinger C and Ziegler D: Postchallenge hyperglycemia
is positively associated with diabetic polyneuropathy: The KORA F4
study. Diabetes Care. 35:1891–1893. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Duby JJ, Campbell RK, Setter SM, White JR
and Rasmussen KA: Diabetic neuropathy: An intensive review. Am J
Health Syst Pharm. 61:160–173; quiz 175–176. 2004.PubMed/NCBI
|
|
5
|
Morrison JF, Shehab S, Sheen R,
Dhanasekaran S, Shaffiullah M and Mensah-Brown E: Sensory and
autonomic nerve changes in the monosodium glutamate-treated rat: A
model of type II diabetes. Exp Physiol. 93:213–222. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Beiswenger KK, Calcutt NA and Mizisin AP:
Epidermal nerve fiber quantification in the assessment of diabetic
neuropathy. Acta Histochem. 110:351–362. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Grisold A, Callaghan BC and Feldman EL:
Mediators of diabetic neuropathy: Is hyperglycemia the only
culprit? Curr Opin Endocrinol Diabetes Obes. 24:103–111. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Román-Pintos LM, Villegas-Rivera G,
Rodríguez-Carrizalez AD, Miranda-Díaz AG and Cardona-Muñoz EG:
Diabetic polyneuropathy in Type 2 diabetes mellitus: Inflammation,
oxidative stress and mitochondrial function. J Diabetes Res.
2016:34256172016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chung SS, Ho EC, Lam KS and Chung SK:
Contribution of polyol pathway to diabetes-induced oxidative
stress. J Am Soc Nephrol. 14(8 Suppl 3): S233–S236. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yakar S, Pennisi P, Wu Y, Zhao H and
LeRoith D: Clinical relevance of systemic and local IGF-I. Endocr
Dev. 9:11–16. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hao CN, Geng YJ, Li F, Yang T, Su DF, Duan
JL and Li Y: Insulin-like growth factor-1 receptor activation
prevents hydrogen peroxide-induced oxidative stress, mitochondrial
dysfunction and apoptosis. Apoptosis. 16:1118–1127. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Puche JE, García-Fernández M, Muntané J,
Rioja J, González-Barón S and Castilla Cortazar I: Low doses of
insulin-like growth factor-I induce mitochondrial protection in
aging rats. Endocrinology. 149:2620–2627. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Carro E, Trejo JL, Núñez A and
Torres-Aleman I: Brain repair and neuroprotection by serum
insulin-like growth factor I. Mol Neurobiol. 27:153–162. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ishii DN: Implication of insulin-like
growth factors in the pathogenesis of diabetic neuropathy. Brain
Res Brain Res Rev. 20:47–67. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Papanas N and Ziegler D: Risk factors and
comorbidities in diabetic neuropathy: An update 2015. Rev Diabet
Stud. 12:48–62. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Menu E, Jernberg-Wiklund H, Stromberg T,
De Raeve H, Girnita L, Larsson O, Axelson M, Asosingh K, Nilsson K,
Van Camp B and Vanderkerken K: Inhibiting the IGF-1 receptor
tyrosine kinase with the cyclolignan PPP: An in vitro and in vivo
study in the 5T33MM mouse model. Blood. 107:655–660. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hargreaves K, Dubner R, Brown F, Flores C
and Joris J: A new and sensitive method for measuring thermal
nociception in cutaneous hyperalgesia. Pain. 32:77–88. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kanazawa Y, Takahashi-Fujigasaki J,
Ishizawa S, Takabayashi N, Ishibashi K, Matoba K, Kawanami D,
Yokota T, Tajima N and Utsunomiya K: The Rho-kinase inhibitor
fasudil restores normal motor nerve conduction velocity in diabetic
rats by assuring the proper localization of adhesion-related
molecules in myelinating Schwann cells. Exp Neurol. 247:438–446.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tesfaye S, Boulton AJ, Dyck PJ, Freeman R,
Horowitz M, Kempler P, Lauria G, Malik RA, Spallone V, Vinik A, et
al: Diabetic neuropathies: Update on definitions, diagnostic
criteria, estimation of severity and treatments. Diabetes Care.
33:2285–2293. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rathur HM and Boulton AJ: The neuropathic
diabetic foot. Nat Clin Pract Endocrinol Metab. 3:14–25. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Capoluongo E, Pitocco D, Santonocito C,
Concolino P, Santini SA, Manto A, Lulli P, Ghirlanda G, Zuppi C and
Ameglio F: Association between serum free IGF-I and IGFBP-3 levels
in type-I diabetes patients affected with associated autoimmune
diseases or diabetic complications. Eur Cytokine Netw. 17:167–174.
2006.PubMed/NCBI
|
|
23
|
Chu Q, Moreland R, Yew NS, Foley J,
Ziegler R and Scheule RK: Systemic insulin-like growth factor-1
reverses hypoalgesia and improves mobility in a mouse model of
diabetic peripheral neuropathy. Mol Ther. 16:1400–1481. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Schmidt RE, Dorsey DA, Beaudet LN, Plurad
SB, Parvin CA and Miller MS: Insulin-like growth factor I reverses
experimental diabetic autonomic neuropathy. Am J Pathol.
155:1651–1660. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Homs J, Pagès G, Ariza L, Casas C, Chillón
M, Navarro X and Bosch A: Intrathecal administration of IGF-I by
AAVrh10 improves sensory and motor deficits in a mouse model of
diabetic neuropathy. Mol Ther Methods Clin Dev. 1:72014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
O'Brien PD, Sakowski SA and Feldman EL:
Mouse models of diabetic neuropathy. ILAR J. 54:259–272. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Russell JW, Cheng HL and Golovoy D:
Insulin-like growth factor-I promotes myelination of peripheral
sensory axons. J Neuropathol Exp Neurol. 59:575–584. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Delaney CL, Russell JW, Cheng HL and
Feldman EL: Insulin-like growth factor-I and over-expression of
Bcl-xL prevent glucose-mediated apoptosis in Schwann cells. J
Neuropathol Exp Neurol. 60:147–160. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhuang HX, Snyder CK, Pu SF and Ishii DN:
Insulin-like growth factors reverse or arrest diabetic neuropathy:
Effects on hyperalgesia and impaired nerve regeneration in rats.
Exp Neurol. 140:198–205. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gao WQ, Shinsky N, Ingle G, Beck K, Elias
KA and Powell-Braxton L: IGF-I deficient mice show reduced
peripheral nerve conduction velocities and decreased axonal
diameters and respond to exogenous IGF-I treatment. J Neurobiol.
39:142–152. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Rabiee A, Krüger M, Ardenkjær-Larsen J,
Kahn CR and Emanuelli B: Distinct signalling properties of insulin
receptor substrate (IRS)-1 and IRS-2 in mediating insulin/IGF-1
action. Cell Signal. 47:1–15. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhou YL, Liu SQ, Yuan B and Lu N: The
expression of insulin-like growth factor-1 in senior patients with
diabetes and dementia. Exp Ther Med. 13:103–106. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Pfäffle R, Kiess W and Klammt J:
Downstream insulin-like growth factor. Endocr Dev. 23:42–51. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Leinninger GM, Backus C, Uhler MD, Lentz
SI and Feldman EL: Phosphatidylinositol 3-kinase and Akt effectors
mediate insulin-like growth factor-I neuroprotection in dorsal root
ganglia neurons. FASEB J. 18:1544–1546. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Qi M and Elion EA: MAP kinase pathways. J
Cell Sci. 118:3569–3572. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Mohammadi R and Saadati A: Influence of
insulin-like growth factor I on nerve regeneration using
allografts: A sciatic nervemodel. J Craniofac Surg. 25:1510–1515.
2014. View Article : Google Scholar : PubMed/NCBI
|
